5.80

0.17% -0.010

After Hours: 5.80

Champions Oncology Inc (CSBR)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Champions Oncology Inc stock is traded at $5.80, with a volume of 7,291. It is down -0.17% in the last 24 hours and down -3.01% over the past month. Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Previous Close:

$5.81

Open:

$5.825

24h Volume:

7,291

Relative Volume:

0.83

Market Cap:

$80.54M

Revenue:

$57.94M

Net Income/Loss:

$-2.34M

P/E Ratio:

-34.81

EPS:

-0.1666

Net Cash Flow:

$3.82M

1W Performance:

-0.51%

1M Performance:

-3.01%

6M Performance:

-9.23%

1Y Performance:

-37.57%

1-Day Range:

$5.80

$5.875

1-Week Range:

$5.80

$6.2131

52-Week Range:

$5.50

$9.95

Champions Oncology Inc Stock (CSBR) Company Profile

Name

Champions Oncology Inc

Sector

Healthcare (1114)

Industry

Biotechnology (623)

Phone

410-369-0365

Address

855 N. WOLFE STREET, BALTIMORE, NJ

Employee

306

Twitter

@ChampsOnco

Next Earnings Date

2026-03-12

Latest SEC Filings

CSBR's Discussions on Twitter

Compare CSBR vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CSBR Champions Oncology Inc	5.80	80.68M	57.94M	-2.34M	3.82M	-0.1666
VRTX Vertex Pharmaceuticals Inc	454.97	113.96B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	78.41B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	40.85B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	42.05B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	29.99B	606.42M	-1.28B	-997.58M	-6.403

Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Sep-12-24	Upgrade	Craig Hallum	Hold → Buy
Nov-18-19	Initiated	The Benchmark Company	Speculative Buy

Champions Oncology Inc Stock (CSBR) Latest News

Mar 25, 2026

Avoiding Lag: Real-Time Signals in (CSBR) Movement - Stock Traders Daily

Mar 25, 2026

Mar 24, 2026

Champions Oncology outlines full year revenue growth and positive adjusted EBITDA targets amid early traction in data business - MSN

Mar 24, 2026

Mar 22, 2026

Nasdaq Moves: What is the Moat Score of Champions Oncology Inc2026 Price Action Summary & Verified Chart Pattern Signals - baoquankhu1.vn

Mar 22, 2026

Mar 21, 2026

Trading Action: How does Champions Oncology Inc score in quality rankingsEarnings Risk Summary & Free Low Drawdown Momentum Trade Ideas - baoquankhu1.vn

Mar 21, 2026

Nasdaq Moves: How correlated is Champions Oncology Inc to the S P5002026 Gainers & Low Volatility Stock Recommendations - baoquankhu1.vn

Mar 21, 2026

Guidance Update: Will Champions Oncology Inc benefit from geopolitical trends2026 Snapshot & Verified Entry Point Signals - baoquankhu1.vn

Mar 21, 2026

Mar 20, 2026

S P Trends: Is Champions Oncology Inc benefiting from innovation trendsMarket Risk Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn

Mar 20, 2026

Mar 18, 2026